Welcome to Dividends Inside
Welcome to Dividends Inside!

The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.

Cryo-Cell International, Inc.

CCEL
$3.51 (- $0.04 - 1.13%)
Last updated: 2026-05-20 11:19 UTC
CCEL Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryMedical Care Facilities
ISINUS2288951088
Market Price3.51
Dividend Yield 17.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 1.0
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyYearly
P/E RatioN/A
EPS-0.06
Market Cap$28.9M
Book Value-1.84
Price to Book-1.95
Beta0.65
52w High8.79
52w Low3.57
Next Earnings DateN/A
About the Company
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Price History